Correlation between prostate needle biopsies and radical prostatectomy specimens: can we predict pathological outcome?

References

• Epstein J I, Allsbrook W C, Jr, Amin M B, Egevad L L. ISUP grading committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005; 29: 1228–1242
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. AJCC Cancer Staging Manual.6th ed. Springer, New York 2002; 309–316
   Google Scholar
• Albertsen P C, Hanley J A, Gleason D F, Barry M J. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 975–980
   PubMed Web of Science ®Google Scholar
• Hammerer P, Huland H, Sparenberg S. Digital rectal examination, imaging and systematic sextant biopsy in identifying operable lymph node-negative prostatic carcinoma. Eur Urol 1992; 22: 281–287
   PubMed Web of Science ®Google Scholar
• Stamey T A, Freiha F S, McNeal J E, et al. Localized prostate cancer: Relationship of tumour volume to clinical significance for treament of prostate cancer. Cancer 1993; 71(3 Suppl)933–938
   PubMed Web of Science ®Google Scholar
• Epstein J I, Walsh P C, Carmichael M, et al. Pathologic and clinical findings to predict tumour extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368–374
   PubMed Web of Science ®Google Scholar
• Peller P A, Young D C, Marmaduke P, et al. Sextant prostate biopsies: a histopathologic correlation with radical prostatectomy specimens. Cancer 1995; 75: 530–538
   PubMed Web of Science ®Google Scholar
• Epstein J I, Pizov G, Walsh P C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993; 71: 3582–3593
   PubMed Web of Science ®Google Scholar
• Theiss M, Wirth M P, Manseck A, et al. Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy. Prostate 1995; 27: 13–17
   PubMed Web of Science ®Google Scholar
• Gerber G S, Thisted R A, Chodak G W, et al. Results of radical prostatectomy in men with locally advanced prostate cancer: Multi-institutional pooled analysis. Eur Urol 1997; 32: 385–390
   PubMed Web of Science ®Google Scholar
• Stamey T A, McNeal J E, Freiha F S, et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139: 1235–1241
   PubMed Web of Science ®Google Scholar
• McNeal J E, Villers A A, Redwine E A, et al. Histologic differentiation, cancer volume and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 1990; 66: 1225–1233
   PubMed Web of Science ®Google Scholar
• Iczkowski K A, Bostwick D G. Prostate biopsy interpretation. Current concepts 1999. Urol Clin North Am 1999; 26: 435–452
   PubMed Web of Science ®Google Scholar
• Epstein J I. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. Am J Surg Pathol 2000; 24: 477–478
   PubMed Web of Science ®Google Scholar
• Silberman M A, Partin A W, Veltri R W, et al. Tumour angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 1997; 79: 772–779
   PubMed Web of Science ®Google Scholar
• Ross J S, Figge H, Bui H X, et al. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer. Cancer 1994; 74: 2811–2818
   PubMed Web of Science ®Google Scholar
• Glinsky G V, Glinskii A B, Stephenson A J, et al. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest 2004; 113: 913–923
   PubMed Web of Science ®Google Scholar
• Egawa S, Suyama K, Matsumoto K, et al. Improved predictability of extracapsular extension and seminal vesical involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology 1998; 52: 433–440
   PubMed Web of Science ®Google Scholar
• Goto Y, Ohari M, Sardino P T. Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report. Int J Urol 1998; 5: 337–342
   PubMedGoogle Scholar
• Wills M L, Sauvageot J, Partin A W, et al. Ability of sextant biopsies to predict radical prostatectomy stage. Urology 1998; 51: 759–764
   PubMed Web of Science ®Google Scholar
• Renshaw A A, Richie J P, Loughlin K R, et al. The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens. Cancer 1998; 83: 748–752
   PubMed Web of Science ®Google Scholar
• Ravery V, Schmid H P, Toublanc M, et al. Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma?. Cancer 1996; 78: 1079–1084
   PubMed Web of Science ®Google Scholar
• Stamey T A, Caldwell M, McNeal J E, et al. The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?. J Urol 2004; 172: 1297–1301
   PubMed Web of Science ®Google Scholar
• Sebo T J, Bock B J, Cheville J C, et al. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumour stage and volume at radical prostatectomy. J Urol 2000; 163: 174–178
   PubMed Web of Science ®Google Scholar
• Grossklaus D J, Coffey C S, Shappell S B, et al. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol 2002; 167: 2032–2036
   PubMed Web of Science ®Google Scholar
• Bostwick D G, Qian J, Bergstralh E, et al. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996; 155: 1361–1367
   PubMed Web of Science ®Google Scholar
• Ozgur A, Onol F F, Turkeri L N. Important preoperative prognostic factors for extracapsular extension, seminal vesical invasion and lymph node involvement in cases with radical retropubic prostatectomy. Int Urol Nephrol 2004; 36: 369–373
   PubMedGoogle Scholar
• Vallancien G, Abbou C C, Ackermann R, . New surgical techniques in the treatment of prostate cancer. 3^rdInternational Consultation on Prostate Cancer – Paris Edition, L Denis, G Bartsch, S Khoury, M Murai, A Partin, et al. Health Publications, Paris 2003; 125–138
   Google Scholar
• Yoon J H, Chen M H, Renshaw A A, et al. Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer. Urology 2002; 60: 454–457
   PubMed Web of Science ®Google Scholar
• Selek U, Lee A, Levy L, et al. Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2003; 57: 963–967
   PubMed Web of Science ®Google Scholar